Viatris Inc
VTRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001792044
No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.6B in total; Greenlight Capital is the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Viatris Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 1,013 | 10 | 979 | −24 |
| Shares | 973.4M | 707.9K | 975.6M | +2.96M (+0.3%) |
| Value | $8.48B | $6.16M | $8.71B | +$244.0M (+2.9%) |
10 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (100)
Institutions that held Viatris Inc at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (124)
Institutions that held Viatris Inc at the end of Q1 2025 and filed for Q2 2025 without it.
Showing the largest 100 of 124 by value.
Not filed for Q2 2025 yet (10)
Institutions that held Viatris Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Credit Agricole S A | 333,537 | $2.91M |
| Rakuten Investment Management, Inc. | 109,095 | $946.9K |
| Mizuho Securities USA LLC | 95,571 | $832.4K |
| Foundry Partners, LLC | 56,740 | $494.2K |
| CAPROCK Group, Inc. | 53,454 | $465.6K |
| Lindbrook Capital, LLC | 25,194 | $219.4K |
| Glenmede Trust Co NA | 21,488 | $187.2K |
| Marcum Wealth, LLC | 11,649 | $101.5K |
| Sandy Spring Bank | 1,062 | $9.25K |
| Grayhawk Investment Strategies Inc. | 148 | $1.29K |